← Back to Screener
PRF Technologies Ltd. Ordinary Shares (PRFX)
Price$1.59
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-74.94%
Price vs S&P 500 (4W)-18.03%
VGM Score9.54
Market Capitalization$1.38M
All Metrics
Book Value / Share (Quarterly)$10.29
P/TBV (Annual)2.21x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-4.76
Price vs S&P 500 (YTD)-58.63%
EPS (TTM)$-12.92
10-Day Avg Trading Volume8.14M
EPS Excl Extra (TTM)$-12.92
EPS (Annual)$-7.47
ROI (Annual)-56.63%
Gross Margin (Annual)-311.76%
Cash / Share (Quarterly)$3.76
ROA (Last FY)-40.32%
EBITD / Share (TTM)$-12.23
ROE (5Y Avg)-221.07%
Cash Flow / Share (Annual)$-4.76
P/B Ratio0.16x
P/B Ratio (Quarterly)0.29x
Net Income / Employee (Annual)$-806,300
Net Interest Coverage (TTM)-361.00x
ROA (TTM)-61.78%
EPS Incl Extra (Annual)$-7.47
Current Ratio (Annual)1.78x
Quick Ratio (Quarterly)1.77x
3-Month Avg Trading Volume1.44M
52-Week Price Return-83.86%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.37
P/S Ratio (Annual)81.25x
Asset Turnover (Annual)0.00x
52-Week High$17.95
EPS Excl Extra (Annual)$-7.47
CapEx CAGR (5Y)-27.52%
26-Week Price Return-67.01%
Quick Ratio (Annual)1.77x
13-Week Price Return-42.18%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.78x
Enterprise Value$-1.74M
Book Value / Share Growth (5Y)-11.45%
Revenue / Employee (Annual)$2,800
Pretax Margin (Annual)-29494.12%
Cash / Share (Annual)$3.76
3-Month Return Std Dev261.26%
Net Income / Employee (TTM)$-1,192,300
ROE (Last FY)-56.63%
EPS Basic Excl Extra (Annual)$-7.47
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-12.92
Receivables Turnover (Annual)0.13x
ROI (TTM)-84.23%
Revenue / Share (Annual)$0.03
Tangible BV / Share (Annual)$1.37
Price vs S&P 500 (52W)-108.22%
Year-to-Date Return-50.47%
5-Day Price Return-21.29%
EPS Normalized (Annual)$-7.47
ROA (5Y Avg)-113.22%
Net Profit Margin (Annual)-28458.82%
Month-to-Date Return-47.00%
Cash Flow / Share (TTM)$-9.03
EBITD / Share (Annual)$-6.73
Operating Margin (Annual)-30129.41%
ROI (5Y Avg)-221.07%
EPS Basic Excl Extra (TTM)$-12.92
P/TBV (Quarterly)2.21x
P/B Ratio (Annual)0.29x
Book Value / Share (Annual)$10.29
Price vs S&P 500 (13W)-50.44%
Beta1.07x
Revenue / Share (TTM)$0.00
ROE (TTM)-84.23%
52-Week Low$1.28
mGradeF
vgmGradeF
Show chart for
Analyst Recommendations
Mar 2025
Apr 2025
May 2025
Jun 2025
2.17
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PRFXPRF Technologies Ltd. Ordinary Shares | — | — | F | $1.59 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
PRF Technologies Ltd is a diversified platform company operating in specialty pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. It specializes in reformulated and sustained-release drug therapies, with PRF-110—its lead candidate based on ropivacaine—targeting the postoperative pain relief market.